Summary by Moomoo AI
On June 28, 2024, Junshengtai Pharmaceutical-B (2511) announced that, according to the plan on January 19, 2024, it will expand its business to the Nandagang Industrial Park, Bohai New Area, Cangzhou City, Hebei Province, China. This move aims to use local preferential policies to establish a raw material production base, enhance supply capabilities, and establish reliable strategic partnerships for its core products in the Chinese market. The company's board of directors believes that this business expansion plan will meet the overall interests of the company and shareholders. Currently, the company is actively communicating with the local government and relevant parties, and will timely release further announcements in accordance with regulations. Investors should exercise caution when trading shares.
